cp-55,940 has been researched along with Osteoarthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astles, PC; Chambers, MG; Guidetti, R; Hollinshead, SP; Johnson, MP; Oskins, J; Palmer, J; Sanderson, A; Stratford, R; Tidwell, MW | 1 |
| Al-Shamma, H; Behan, DP; Chen, C; Chen, R; Choi, K; Dang, H; Decaire, M; Edwards, J; Fu, L; Gaidarov, I; Gatlin, J; Han, S; Jones, RM; Jung, JK; Morgan, M; Narayanan, S; Pride, C; Sadeque, A; Semple, G; Solomon, M; Strah-Pleynet, S; Thatte, J; Thoresen, L; Unett, DJ; Usmani, KA; Whelan, K; Xiong, Y; Yue, D; Zhu, X | 1 |
2 other study(ies) available for cp-55,940 and Osteoarthritis
| Article | Year |
|---|---|
Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain.
Topics: Animals; Dogs; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Male; Osteoarthritis; Purines; Rats; Rats, Inbred Lew; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2013 |
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Arthritis, Experimental; Heterocyclic Compounds, 3-Ring; Humans; Inflammation; Male; Microsomes, Liver; Models, Molecular; Molecular Structure; Osteoarthritis; Pain; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stereoisomerism; Structure-Activity Relationship | 2015 |